Glenview Capital Management, Llc
Source: SEC Form 13F · as of Mar 2026Glenview Capital Management, Llc holds 5 biotech & pharma companies tracked by BioSniper, totaling $367.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$367.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Teva Pharmaceutical Industries Limited (TEVA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | 6,660,220 | $200.6M |
| VTRSViatris Inc | 9,087,244 | $122.8M |
| MYGNMYRIAD GENETICS INC | 5,411,978 | $24.4M |
| BIIBBIOGEN INC. | 57,019 | $10.5M |
| TECHBIO-TECHNE Corp | 186,312 | $9.7M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.